Munther A. Khamashta
#103,887
Most Influential Person Now
Munther A. Khamashta's AcademicInfluence.com Rankings
Munther A. Khamashtamedical Degrees
Medical
#1256
World Rank
#1576
Historical Rank
Rheumatology
#6
World Rank
#6
Historical Rank

Munther A. Khamashtabiology Degrees
Biology
#5338
World Rank
#7795
Historical Rank
Immunology
#247
World Rank
#257
Historical Rank
Neuroscience
#587
World Rank
#613
Historical Rank

Download Badge
Medical Biology
Munther A. Khamashta's Degrees
- Doctorate Medicine University of Baghdad
Why Is Munther A. Khamashta Influential?
(Suggest an Edit or Addition)Munther A. Khamashta's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2011) (3649)
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. (1999) (2685)
- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. (2002) (1813)
- Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients (2003) (1214)
- The management of thrombosis in the antiphospholipid-antibody syndrome. (1995) (1073)
- The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features (1989) (998)
- Adult haemophagocytic syndrome (2014) (938)
- Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients (1993) (909)
- Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines (2003) (743)
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation (2016) (714)
- Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases (2007) (696)
- Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus (2017) (585)
- Systemic lupus erythematosus (2001) (578)
- Anti-inflammatory and immunosuppressive drugs and reproduction (2006) (548)
- EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) (511)
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome (2015) (509)
- International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies (2013) (471)
- Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. (1994) (471)
- Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies (2011) (458)
- Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. (2003) (457)
- Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients (1999) (389)
- Antiphospholipid antibodies (1994) (382)
- Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort (2014) (377)
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study (2016) (371)
- Immune-related adverse events of checkpoint inhibitors (2020) (360)
- Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus (2012) (353)
- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. (2016) (341)
- Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. (1989) (328)
- Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. (1997) (313)
- Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus (1990) (309)
- Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
- Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. (2000) (306)
- Autoimmune diseases induced by TNF-targeted therapies. (2008) (305)
- A study of sixty pregnancies in patients with the antiphospholipid syndrome. (1996) (302)
- The frequency and outcome of lupus nephritis: results from an international inception cohort study. (2016) (301)
- A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. (2007) (293)
- Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial (2016) (292)
- Autoimmune diseases induced by biological agents: a double-edged sword? (2010) (289)
- The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome (1998) (285)
- Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. (2001) (251)
- Antiphospholipid syndrome (2010) (248)
- The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. (2009) (243)
- Thromboprophylaxis with Low Molecular Weight Heparin (Fragmin) in High Risk Pregnancies (1997) (242)
- GAPSS: the Global Anti-Phospholipid Syndrome Score. (2013) (228)
- Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. (1990) (227)
- Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. (1997) (226)
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults (2018) (226)
- Systemic lupus erythematosus and pregnancy. (2006) (225)
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts. (2012) (221)
- Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients (1998) (214)
- Oxidation of LDL and its clinical implication. (2008) (213)
- Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus (2004) (196)
- Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. (2006) (195)
- Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. (2003) (192)
- Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. (1996) (192)
- The clinical spectrum of autoimmune congenital heart block (2015) (192)
- Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome (2013) (188)
- Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. (1995) (187)
- Glucocorticoid use and abuse in SLE. (2012) (183)
- Assessing disease activity in SLE patients during pregnancy (1999) (176)
- Seronegative antiphospholipid syndrome (2003) (172)
- Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus (2010) (167)
- Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. (2000) (167)
- Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. (2010) (166)
- Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. (1994) (166)
- Can Neurologic Manifestations of Hughes (Antiphospholipid) Syndrome Be Distinguished from Multiple Sclerosis?: Analysis of 27 Patients and Review of the Literature (2000) (165)
- The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. (2015) (164)
- The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients (2010) (159)
- Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome (2010) (157)
- Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. (2002) (157)
- Central nervous system involvement in the antiphospholipid (Hughes) syndrome. (2003) (155)
- Acute Viral Infections in Patients With Systemic Lupus Erythematosus: Description of 23 Cases and Review of the Literature (2008) (154)
- Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. (1996) (152)
- First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. (2011) (151)
- Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. (2003) (151)
- beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. (1994) (150)
- Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. (2002) (146)
- Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. (2004) (145)
- The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. (2016) (144)
- The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. (2004) (135)
- Long-Term Follow-Up in 128 Patients With Primary Antiphospholipid Syndrome: Do They Develop Lupus? (2005) (133)
- Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis (2011) (133)
- Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. (1993) (132)
- Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study (2012) (132)
- Treatment of pregnant patients with antiphospholipid syndrome (2003) (131)
- Thrombocytopenia in the antiphospholipid syndrome (1997) (128)
- Obstetric outcome in systemic lupus erythematosus. (1995) (128)
- Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. (1998) (128)
- High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome (1991) (127)
- Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. (2015) (125)
- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. (2016) (125)
- Numerical scoring for the BILAG-2004 index (2010) (124)
- Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. (1998) (123)
- Seronegative antiphospholipid syndrome. (2013) (122)
- Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. (1988) (122)
- Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide (1997) (122)
- Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances (2017) (121)
- Features associated with epilepsy in the antiphospholipid syndrome. (2004) (121)
- Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis (1991) (121)
- Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report (2003) (120)
- Pregnancy and reproduction in autoimmune rheumatic diseases. (2011) (120)
- Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. (2004) (119)
- Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. (1998) (119)
- Management of the obstetric antiphospholipid syndrome. (2004) (116)
- The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review (2014) (114)
- Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. (1995) (114)
- Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity (1993) (113)
- Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort (2012) (111)
- Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. (2002) (110)
- Antiprothrombin antibodies detected in two different assay systems (2005) (110)
- Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. (1997) (109)
- Antiphospholipid antibodies and antiphospholipid syndrome (1995) (109)
- Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called ‘seronegative APS’) (2011) (107)
- Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension (2003) (107)
- The placental bed in pregnancies complicated by primary antiphospholipid syndrome. (2006) (106)
- The BILAG-2004 index is sensitive to change for assessment of SLE disease activity (2009) (104)
- GAPSS : the Global AntiPhospholipid Syndrome Score (2013) (102)
- Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. (1994) (102)
- The efficacy of novel B cell biologics as the future of SLE treatment: a review. (2014) (101)
- Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies (2003) (101)
- Prophylaxis of the antiphospholipid syndrome: a consensus report (2003) (99)
- Pregnancy in systemic lupus erythematosus. (1996) (99)
- Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. (1998) (98)
- The central nervous system in systemic lupus erythematosus (2004) (98)
- British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus (2007) (97)
- Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. (2000) (97)
- Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature (1995) (96)
- Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. (2012) (95)
- Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. (1996) (94)
- The hematologic manifestations of the antiphospholipid syndrome. (2008) (93)
- Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome (2006) (93)
- Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. (2006) (93)
- Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. (2010) (92)
- Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. (2006) (90)
- Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review (2014) (90)
- Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. (2004) (88)
- Major histocompatibility complex associations with primary antiphospholipid syndrome. (1992) (88)
- Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study (2014) (87)
- Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. (1998) (87)
- Mycophenolate mofetil treatment in resistant myositis. (2007) (86)
- Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. (1989) (85)
- Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. (2013) (84)
- Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. (1988) (83)
- Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil) (2006) (82)
- Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. (1989) (82)
- Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. (1998) (80)
- Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. (1992) (80)
- Lupus and pregnancy: integrating clues from the bench and bedside (2011) (80)
- A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β2‐glycoprotein I–dependent anticardiolipin and anti–β2‐glycoprotein I antibodies (1999) (80)
- Patterns of systemic lupus erythematosus expression in Europe. (2014) (79)
- Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 (2003) (79)
- Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. (2011) (78)
- McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome (2018) (78)
- The global anti-phospholipid syndrome score in primary APS. (2015) (77)
- Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. (1995) (77)
- Release of calreticulin from neutrophils may alter C1q-mediated immune functions. (1997) (76)
- The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. (1997) (75)
- Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE (2015) (75)
- Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). (2014) (75)
- Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment. (2012) (75)
- Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. (2005) (75)
- Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. (2004) (75)
- The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. (2006) (74)
- Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus (2014) (74)
- Systemic lupus erythematosus. (1977) (73)
- The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review. (2013) (72)
- Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. (1997) (72)
- Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. (1991) (71)
- Prednisone in lupus nephritis: how much is enough? (2014) (70)
- Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. (2008) (70)
- Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort (2014) (69)
- Systemic Lupus Erythematosus: Sex Hormones in Male Patients (1993) (68)
- Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort (2019) (67)
- Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: A myth or an existing entity? (2010) (67)
- Migraine and stroke in young women. (2000) (66)
- Antiphospholipid syndrome and the kidneys. (2006) (65)
- Antiphospohlipid syndrome in obstetrics. (2012) (65)
- Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. (1990) (65)
- Low dose methotrexate treatment in adult Still's disease. (1992) (65)
- Prevalence of the antiphospholipid syndrome in primary systemic vasculitis (2005) (65)
- Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study (2018) (65)
- Endothelial Cells as a Target for Antiphospholipid Antibodies: Role of Anti‐Beta 2 Glycoprotein I Antibodies (1997) (65)
- Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. (2013) (64)
- Plasma Tumor Necrosis Factor α Levels and the –238* A Promoter Polymorphism in Patients with Antiphospholipid Syndrome (2001) (64)
- Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome (2003) (64)
- Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. (1996) (64)
- 25‐Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort (2014) (63)
- Vasculitis induced by tumor necrosis factor-targeted therapies (2008) (63)
- Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not! (2009) (63)
- Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies (2017) (62)
- A Study of 100 High Risk Lupus Pregnancies (1992) (61)
- A need for standardization of the anti-endothelial-cell antibody test. (1995) (60)
- Management of antiphospholipid syndrome (2018) (59)
- The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies (2015) (58)
- Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis. (2008) (57)
- Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. (2008) (57)
- Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study (2003) (57)
- Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome. (2010) (55)
- Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment (2014) (55)
- Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. (1998) (55)
- Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data (2004) (55)
- Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant (2012) (55)
- ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies. (1993) (53)
- Laboratory diagnosis and management challenges in the antiphospholipid syndrome (2006) (53)
- Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. (2003) (53)
- Towards a better understanding of the clinical association of anti-DFS70 autoantibodies. (2016) (53)
- Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR). (2019) (52)
- Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments (1994) (52)
- Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. (1995) (51)
- Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al. (2009) (51)
- B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. (2013) (51)
- HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. (2001) (51)
- Renal involvement in antiphospholipid syndrome (2014) (51)
- Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. (1999) (51)
- Neuropsychiatric Involvement in Systemic Lupus Erythematosus (2011) (50)
- Management of pregnancy in antiphospholipid syndrome. (2001) (50)
- Allergic Disorders in Systemic Lupus Erythematosus (1993) (50)
- Management of refractory anti-phospholipid syndrome. (2011) (50)
- Thrombotic Risk Assessment in Systemic Lupus Erythematosus: Validation of the Global Antiphospholipid Syndrome Score in a Prospective Cohort (2014) (49)
- Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease. (1991) (49)
- Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies (2015) (48)
- A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. (1999) (48)
- Anti‐endothelial cell antibodies: only for scientists or for clinicians too? (1996) (48)
- Development and initial validation of a self‐assessed lupus organ damage instrument (2010) (47)
- Pregnancy in granulomatous vasculitis. (1995) (47)
- Management of Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Pregnancy (2005) (47)
- Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. (1992) (47)
- Nonsteroidal Anti-Inflammatory Drugs and Reversible Female Infertility (2002) (47)
- Warfarin and azathioprine: a drug interaction does exist. (1993) (47)
- Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus (2018) (47)
- Thymulin modulates cytokine release by peripheral blood mononuclear cells: a comparison between healthy volunteers and patients with systemic lupus erythematosus. (1993) (47)
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary. (2018) (47)
- European Attempts to Set Guidelines for Improving Diagnostics of Autoimmune Rheumatic Disorders (2006) (47)
- Placentation, antiphospholipid syndrome and pregnancy outcome (2001) (45)
- Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. (1992) (45)
- Antiphospholipid (Hughes') syndrome (1997) (45)
- Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study (2018) (45)
- Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. (2005) (45)
- Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. (2016) (45)
- Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment (2001) (44)
- Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. (2005) (44)
- Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies. (2000) (44)
- Antiphospholipid syndrome: linking many specialties. (1989) (43)
- Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence (2011) (43)
- Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. (2000) (43)
- Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism (2016) (43)
- Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. (1999) (42)
- Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. (1999) (42)
- Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus (2003) (42)
- Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block. (2001) (42)
- Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance (2003) (42)
- Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: What advice should we be giving? (2001) (42)
- Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. (1992) (41)
- Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome (2014) (41)
- Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. (1994) (41)
- Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome (2016) (41)
- Thromboprophylaxis in Antiphospholipid Syndrome Pregnancies with Previous Cerebral Arterial Thrombotic Events: Is Warfarin Preferable? (1998) (41)
- Malignancy in Systemic Lupus Erythematosus: a Report of Five Cases in a Series of 96 Patients (1993) (41)
- B-cell-depleting therapy in systemic lupus erythematosus. (2012) (41)
- Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome (2011) (41)
- Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. (1999) (40)
- Systemic lupus erythematosus in 50 year olds. (1992) (40)
- Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future (2010) (40)
- HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. (1992) (39)
- Up-Regulated Tissue Factor Expression in Antiphospholipid Syndrome (1997) (39)
- Cardiac valve replacement in patients with antiphospholipid syndrome (2012) (39)
- Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome. (1998) (39)
- Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. (2015) (39)
- Numerical scoring for the Classic BILAG index (2009) (38)
- Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome (2012) (38)
- Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study (2019) (38)
- Headache and memory loss: rapid response to heparin inthe antiphospholipid syndrome (2001) (38)
- Atherosclerosis and autoimmunity (2001) (38)
- The hepatic complications of the antiphospholipid antibodies. (1991) (37)
- Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. (2004) (37)
- Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome. (2012) (37)
- Intensity and Duration of Anticoagulation Therapy in Antiphospholipid Syndrome (2012) (37)
- Anti-β2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome (2007) (37)
- Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures (2004) (37)
- Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. (1991) (36)
- Determination of autoantibodies to annexin XI in systemic autoimmune diseases (2000) (36)
- Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. (1998) (36)
- Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort (2018) (36)
- Sticky blood and headache (2001) (36)
- Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event (2003) (35)
- High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. (2012) (35)
- Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? (1996) (35)
- Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis (2000) (35)
- Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome (2001) (34)
- Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. (1999) (34)
- 10 Years of belimumab experience: What have we learnt? (2021) (34)
- Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. (2001) (34)
- Prothrombin Mutation Is not Associated with Thrombosis in Patients with Antiphospholipid Syndrome (1998) (34)
- Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study (2020) (33)
- Antiphospholipid syndrome and renal artery stenosis. (2000) (33)
- Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. (1992) (33)
- Antiphospholipid syndrome in pregnancy. (2007) (33)
- How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. (2007) (32)
- Thymulin and its role in immunomodulation. (1992) (32)
- Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. (2005) (32)
- A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach (2016) (32)
- Hughes Syndrome: History (2000) (32)
- EASI—The European Autoimmunity Standardisation Initiative (2007) (32)
- Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. (2000) (31)
- Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I. (2003) (31)
- Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus (2019) (30)
- Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review. (2017) (30)
- Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome. (1995) (30)
- New Tests to Detect Antiphospholipid Antibodies: Antiprothrombin (aPT) and Anti-Phosphatidylserine/Prothrombin (aPS/PT) Antibodies (2014) (29)
- Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children. (1997) (29)
- Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. (2000) (29)
- The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients (2012) (29)
- Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. (2008) (29)
- Migraine in Hughes syndrome--heparin as a therapeutic trial? (2001) (29)
- Hughes syndrome crosses boundaries. (2002) (29)
- Association of Thrombotic Microangiopathy and Intimal Hyperplasia With Bleeding Post–Renal Biopsy in Antiphospholipid Antibody–Positive Patients (2014) (29)
- [Adaptation and validation of the Spanish version of a disease-specific quality of life measure in patients with systemic lupus erythematosus: the Lupus quality of life]. (2010) (29)
- Management of antiphospholipid syndrome. (2009) (29)
- Antiphospholipid antibodies and the endothelium (2000) (29)
- Autoantibodies in systemic lupus erythematosus and urticarial vasculitis. (1995) (28)
- American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort (2014) (28)
- Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies. (2002) (28)
- Treatment of pregnancy loss in Hughes syndrome: a critical update. (2002) (28)
- Allergic disorders in systemic vasculitis: a case-controlled study. (1994) (28)
- Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant? (2000) (28)
- Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus (2001) (28)
- Fcγ Receptor IIA H/R131 Polymorphism in Patients with Antiphospholipid Antibodies (1998) (27)
- Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome (2012) (27)
- The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects. (2000) (27)
- Antiphospholipid (Hughes) Syndrome (2004) (26)
- Evidence for sexual dimorphism of estrogen receptors in hypothalamus and thymus of neonatal and immature Wistar rats. (1999) (26)
- The Antiphospholipid Syndrome (1996) (26)
- Heparin and osteoporosis during pregnancy: 2002 update (2002) (26)
- Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus (2019) (26)
- Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity. (1999) (25)
- Minocycline-induced arthritis. (1998) (25)
- Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1 (2016) (24)
- Systemic lupus erythematosus (2001) (23)
- AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS (2007) (23)
- Hypertension as the presenting feature of the antiphospholipid syndrome (2002) (23)
- Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. (2000) (23)
- Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients. (2014) (23)
- Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. (1995) (23)
- Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. (1992) (23)
- Managing lupus patients during pregnancy. (2009) (23)
- Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. (2008) (22)
- Syndrome X and Hughes syndrome (2002) (22)
- Antibodies Against Platelet-Activating Factor in Patients with Antiphospholipid Antibodies (1994) (22)
- Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus (2006) (22)
- Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. (2020) (22)
- Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. (1998) (22)
- Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. (2000) (22)
- Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index (2020) (21)
- Development of the Asia Pacific Lupus Collaboration cohort (2018) (21)
- Effects of β2‐glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions (2002) (21)
- Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study (2006) (21)
- The treatment of antiphospholipid syndrome: a harmonic contrast. (2007) (21)
- Antiphospholipid syndrome: an update (2015) (21)
- Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort (2021) (20)
- Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis. (2005) (20)
- Non-infective verrucous endocarditis in a patient with 'primary' antiphospholipid syndrome. (1991) (20)
- Estrogen and progesterone receptors in murine models of systemic lupus erythematosus. (2001) (20)
- Diagnosis of antiphospholipid syndrome (2005) (20)
- Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome. (1999) (20)
- Is it time for biosimilars in autoimmune diseases? (2013) (20)
- Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. (2002) (20)
- Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol (2005) (19)
- Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. (2003) (19)
- Antibodies to Endothelial Cells and Vascular Damage (1993) (19)
- IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome. (1992) (19)
- Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. (2003) (19)
- Targeted therapy in antiphospholipid syndrome (2014) (18)
- Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? (2016) (18)
- Antiphospholipid antibody syndrome. (1994) (18)
- Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach (2018) (18)
- Drugs Targeting B-Cells in Autoimmune Diseases (2014) (18)
- Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projects (2006) (18)
- Therapeutic advances in systemic lupus erythematosus. (1998) (17)
- Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis. (2001) (17)
- Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus (2003) (17)
- Polymyositis-dermatomyositis: a clinical review. (1989) (17)
- Antiphospholipid antibodies in homozygous sickle cell disease. (1992) (17)
- Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies. (1990) (17)
- Management of the antiphospholipid syndrome. (1991) (17)
- Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. (1992) (16)
- Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus (2020) (16)
- Hughes syndrome : antiphospholipid syndrome (2000) (16)
- 6 Antiphospholipid syndrome in SLE (1998) (16)
- Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation. (2021) (16)
- Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India. (1990) (15)
- The DWEYS peptide in systemic lupus erythematosus. (2012) (15)
- Rheumatological complications of beta-thalassaemia: an overview. (2018) (15)
- ‘Seronegative antiphospholipid syndrome’: an update (2019) (15)
- Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH3. (1991) (15)
- Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma (2019) (15)
- Therapy of systemic lupus erythematosus: new agents and new evidence (2000) (15)
- Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. (2019) (15)
- IgG2 restriction of anti-beta2-glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: comment on the article by Sammaritano et al. (1998) (15)
- Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort (2018) (14)
- ‘A new dawn of anticoagulation for patients with antiphospholipid syndrome?’ (2012) (14)
- THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY) (2019) (14)
- Distribution of Two Common Idiotypes of Anticardiolipin Antibodies in Sera of Patients with Primary Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Monoclonal Gammopathies (1992) (14)
- Impaired estrogen priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). (2000) (14)
- Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy. (2000) (14)
- Systemic Lupus Erythematosus in Males: Analysis of Clinical and Laboratory Features (1992) (14)
- Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? (2017) (14)
- Lack of association of antibodies to ribosomal P proteins with lupus membranous glomerulonephritis: comment on the article by Do Nascimento et al. (2006) (14)
- Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. (2007) (14)
- SYSTEMIC LUPUS ERYTHEMATOSUS AND RELATED SYNDROMES (1992) (14)
- Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE). (2001) (13)
- The ANCA test: its clinical relevance. (1990) (13)
- Complement factor 2 deficiency: a clinical and serological family study. (1992) (13)
- Most anticardiolipin antibodies in mixed connective tissue disease are beta2-glycoprotein independent. (1998) (13)
- Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort (2019) (13)
- 'Overlap' syndromes. (1990) (13)
- Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach (2020) (13)
- Antiphospholipid antibodies and risk for recurrent vascular events. (2004) (13)
- Hypertension and the antiphospholipid antibodies. (1993) (13)
- A normal ECG at birth does not exclude significant congenital cardiac conduction disease associated with maternal anti-Ro antibodies. (2001) (13)
- Musculoskeletal manifestations of the antiphospholipid syndrome (2016) (12)
- The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally (2012) (12)
- Antiphospholipid antibodies do not a syndrome make (2002) (12)
- ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS (1988) (12)
- Antiphospholipid syndrome: a consensus for treatment? (2003) (12)
- Management of the Hughes syndrome. (1996) (12)
- Antiphospholipid syndrome in SLE. (1998) (12)
- Current status and future prospects for the treatment of antiphospholipid syndrome (2016) (11)
- Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis (2006) (11)
- Systemic lupus erythematosus in pregnancy (2004) (11)
- Antiphospholipid antibodies--middle aged but robust. (1994) (11)
- An evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of arterial thrombosis in patients with the antiphospholipid syndrome. (2000) (11)
- Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome (2003) (11)
- Sneddon's syndrome (1989) (10)
- Advances in antiphospholipid (Hughes') syndrome. (1998) (10)
- Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. (1991) (10)
- Multiple sclerosis and the antiphospholipid (Hughes) syndrome: a common differential diagnosis? (2004) (10)
- [Antiphospholipid syndrome in obstetrics]. (2012) (10)
- Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort (2020) (10)
- Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort. (2021) (10)
- Possible mechanisms of action of the antiphospholipid binding antibodies. (1989) (10)
- Specificity of estrogen receptors in rat thymus. (1993) (10)
- Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients. (2001) (10)
- Systemic lupus erythematosus - Reply (2001) (10)
- [Antiendothelial cell antibodies]. (1990) (9)
- GAPSS: the Global Anti-Phospholipid Syndrome Score RHEUMATOLOGY (2013) (9)
- Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop? (2013) (9)
- Goldblatt's kidney, Hughes syndrome and hypertension (2002) (9)
- A Comparison of 2019 EULAR/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria. (2020) (9)
- Antiphospholipid antibodies, valvular heart disease and systemic lupus erythematosus. (1989) (9)
- N2010 adult-onset Still's disease complicated by hemophagocytic syndrome and catastrophic antiphospholipid syndrome resulting in four limb amputation. (2013) (9)
- Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria (2021) (9)
- Postpartum spontaneous colonic perforation due to antiphospholipid syndrome. (2009) (9)
- Autoimmune diseases : acute and complex situations (2011) (8)
- Recurrent atraumatic metatarsal, rib and sacral insufficiency fractures in a woman with the antiphospholipid syndrome (2013) (8)
- Phospholipid Autoantibodies — Cardiolipin (1996) (8)
- Cancer risk in a large inception SLE cohort: Effects of demographics, smoking, and medications. (2020) (8)
- Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis. (2003) (8)
- Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply. (2018) (8)
- Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease. (2018) (8)
- Pregnancy outcomes in mixed connective tissue disease: a multicentre study. (2019) (8)
- Genetics of antiendothelial cell antibodies in systemic lupus erythematosus: the role of HLA-DP alleles. (1992) (8)
- [B-cell-depletion therapy in systemic autoinmune diseases. Recommendations for use in clinical practice]. (2011) (7)
- Thrombocytopenia in the antiphospholipid syndrome. (1997) (7)
- Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting! (2004) (7)
- O58. Longterm Outcomes of Children Born to Mothers with SLE Exposed to Hydroxychloroquine in Pregnancy (2014) (7)
- Prevalence of hypertension in 600 patients with antiphospholipid syndrome. (2003) (7)
- [Anti-endothelial cell antibodies in systemic lupus erythematosus: association with vascular and renal lesions]. (1992) (7)
- Circulating oxidized LDL forms complexes with β2-glycoprotein I Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200329-JLR200 (2003) (7)
- RAPS: a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE (2013) (7)
- Antibodies against endothelial cells in patients with multiple sclerosis (1996) (7)
- Practical management of pregnancy in systemic lupus erythematosus (1993) (7)
- Heart Disease, Pregnancy and Systemic Autoimmune Diseases (2007) (7)
- Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. (2019) (7)
- [Treatment of systemic lupus erythematosus: myths, certainties and doubts]. (2013) (6)
- Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease. (2012) (6)
- Lupus, thrombotic thrombocytopenic purpura, and antiphospholipid antibodies (1989) (6)
- 139 – Antiphospholipid syndrome: Overview of pathogenesis, diagnosis, and management (2015) (6)
- Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement. (1995) (6)
- Is there a role for phospholipases in the anti-cardiolipin syndrome? (1988) (6)
- Anti-PL4 antibody in SLE. (1998) (6)
- Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index (2020) (6)
- European Working Party on Systemic Lupus Erythematosus: a 10 year report (2001) (6)
- Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions. (2002) (6)
- Polymyositis complicating D-penicillamine treatment. (1991) (6)
- The association of pure red cell aplasia with the antiphospholipid syndrome (2001) (6)
- Aspirin to treat obstetric manifestations of the antiphospholipid syndrome. (2001) (6)
- Clinical significance of anti-beta 2-glycoprotein I antibodies. (1996) (5)
- Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism (2015) (5)
- [Orthopedic manifestations of the antiphospholipid syndrome]. (2007) (5)
- Cerebral embolism complicating Libman-Sacks endocarditis--full recovery using recombinant tissue plasminogen activator. (2002) (5)
- Multiple small-vessel occlusions in systemic lupus erythematosus. (1989) (5)
- Double blind, crossover, randomised trial comparing low molecular weight heparin versus placebo in the treatment of chronic headache (2003) (5)
- [Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts]. (2016) (5)
- The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus (2013) (5)
- Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy. (2003) (5)
- Markers of vascular damage in lupus pregnancy. (1997) (4)
- Antiphospholipid antibodies: which and when? (1990) (4)
- [Diagnosis of antiphospholipid syndrome: From an historical perspective to the emergence of new autoantibodies]. (2016) (4)
- THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY) (2019) (4)
- Correlation between b 2-glycoprotein I valine / leucine 247 polymorphism and anti- b 2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome (1999) (4)
- Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus. (1993) (4)
- Manifestations osseuses du syndrome des antiphospholipides (2007) (4)
- The clinical aspects of the antiphospholipid syndrome (2004) (4)
- Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment (2017) (4)
- Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE) (1997) (4)
- Antiphospholipid Syndrome Handbook (2010) (3)
- Antiphospholipid Syndrome and Atherosclerosis (2001) (3)
- Psychiatric disorders in patients with systemic lupus erythematosus: lack of association with antiphospholipid antibodies. (1993) (3)
- Clinical significance of anti-β2-glycoprotein I antibodies (1996) (3)
- How I treat How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome : a case-based review (2007) (3)
- Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications (2021) (3)
- [Avascular necrosis of the bone and systemic lupus erythematosus]. (1987) (3)
- Prevalence of headache and relationship with the presence of antiphospholipid antibodies in systemic lupus erythematosus (2000) (3)
- Antiphospholipid antibodies in a Brazilian population with systemic lupus erythematosus. (1989) (3)
- Echocardiography and digital subtraction angiography in detection of mycotic false aneurysm complicating coarctation of the aorta. (1988) (3)
- Antiphospholipid antibodies hasten atheroma (1996) (3)
- Anticoagulation for venous thromboembolism. (1999) (3)
- Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians. (2018) (3)
- A new role for antimalarials in systemic lupus erythematosus treatment (2010) (3)
- Anticardiolipin Antibodies in Isolated Retinal Vasculitis (1993) (3)
- Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset (2021) (3)
- Prolactin, the immune response and lupus. (1999) (3)
- Anti-Ro and Lymphopenia in SLE (1993) (3)
- Antiphospholipid syndrome: treatment controversies (2006) (3)
- Oral Abstracts 1: Connective Tissue DiseaseO1. Long-Term Outcomes of Children Born to Mothers with SLE (2013) (3)
- Seronegative antiphospholipid syndrome. Author's reply (2004) (3)
- The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome (2007) (3)
- Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now? (2020) (2)
- Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? (2016) (2)
- The prevalence of an abnormal ankle-brachial index in primary Antiphospholipid Syndrome. (2003) (2)
- 262 Longitudinal Assessment of Systemic Lupus Erythematosus Disease Activity: British Isles Lupus Assessment Group 2004, Systemic Lupus Erythematosus Disease Activity Index 2000 or Both? (2016) (2)
- B-cell-depleting Therapy in Systemic Lupus (2012) (2)
- Lupus and pregnancy in the 21st century (2014) (2)
- [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome]. (1992) (2)
- The importance of antiphospholipid antibodies. (1990) (2)
- Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE (2015) (2)
- Managing Lupus Nephritis in Pregnant Women: Comment on the Article by Hahn et al (2013) (2)
- [Anti-phospholipid antibodies]. (1988) (2)
- OP0299-PARE Attitudes of Patients and Physicians in the Treatment of Rheumatological Disease During Pregnancy (2015) (2)
- Hughes Syndrome: Highways and Byways (2013) (2)
- an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. (2016) (2)
- Connective tissue disease: Trial of SLE therapies in real-world settings (2012) (2)
- [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. (1992) (2)
- AB0487 Antiphospholipid Syndrome and Epilepsy: Where Do We Stand? (2016) (2)
- Antiphospholipid syndrome. (1999) (2)
- Chapter 27 – Cardiopulmonary Disease in SLE (2013) (2)
- Outcome in patients with anticardiolipin antibodies: A prospective 4 years follow-up (2000) (2)
- Management of APS (2010) (2)
- Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine (2022) (2)
- Anticardiolipin antibody. (1989) (2)
- Rivaroxaban limits complement activation in patients with thrombotic antiphospholipid syndrome (2015) (2)
- Antiphosphatidylserine/Prothrombin Antibodies in Systemic Lupus Erythematosus (2013) (1)
- Cerebrovascular disease in the Hughes/antiphospholipid syndrome (APS) (2000) (1)
- Anti-Dense Fine Speckled 70 Autoantibodies in Systemic Lupus 1 The Prevalence and Determinants of Anti-DFS 70 Autoantibodies in an International Inception Cohort of Systemic Lupus Erythematosus Patients Running Head : Anti-Dense Fine Speckled 70 Autoantibodies in SLE 1 (2018) (1)
- Hughes Syndrome: A Short History of Antiphospholipid Syndrome (1999) (1)
- Unusual Clinical Manifestations of the Antiphospholipid Syndrome (2006) (1)
- Handbook of Systemic Autoimmune Diseases (2016) (1)
- Hughes Syndrome (2000) (1)
- Thromboprophylaxis with low molecular weight heparin during pregnancy (1994) (1)
- Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome (2012) (1)
- Antibodies to beta2-glycoprotein I (1998) (1)
- prospective study of 1,000 patients syndrome during a 5-year period: a multicenter Morbidity and mortality in the antiphospholipid (2009) (1)
- Eular On-line Course on Rheumatic Diseases - module n°19 (2008) (1)
- Revisiting antiphospholipid antibodies (2004) (1)
- Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study (2017) (1)
- Antiphospholipid antibodies, thrombosis and vasculitis. Proceedings of a symposium. London, 16th December 1988. (1989) (1)
- O15. Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multi-Centre Register (2015) (1)
- Rituximab in SLE (2012) (1)
- Anticardiolipin antibodies in isolated retinal vasculitis. (1994) (1)
- 123. A Systematic Analysis of the Safety of Prescribing Anti-Rheumatic Immunosuppressive and Biologic Drugs in Pregnant Women with Inflammatory Arthritis (2014) (1)
- Seronegative antiphospholipid syndrome - Reply (2004) (1)
- Treatment of antiphospholipid antibody syndrome (2010) (1)
- [Hughes syndrome: anticardiolipin or antiphospholipid]. (1995) (1)
- Renal artery stenosis in hypertensive patients with antiphosphotipid syndrome: The effects of anticoagulation. (2003) (1)
- Antiphospholipid (Hughes) syndrome - Preface (2001) (1)
- THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome (2017) (1)
- Diagnosis of antiphospholipid syndrome (2008) (1)
- [Determination of beta-2-microglobulin levels in patients with systemic lupus erythematosus: correlation with clinical and biological parameters]. (1987) (1)
- Sneddon's syndrome and primary anti‐phospholipid syndrome (PAPS) (1990) (1)
- FRI0093 A Systematic Analysis of the Safety of Prescribing of Anti-Rheumatic, Immunosuppressive and Biologic Drugs in Men Trying to Conceive (2013) (1)
- Protein S, C4b-binding protein (C4BP) and beta 2-glycoprotein I (??2-GPI) binding interaction: Inhibition by human monoclonal anticardiolipin antibody (Mo-aCL) (1995) (1)
- Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts (2016) (1)
- Comparison of responsiveness of BILAG-2004, SLEDAI-2000 and BILAG Systems Tally (BST). (2021) (1)
- Irrational testing for antiphospholipid antibodies (2013) (1)
- [Hughes syndrome and thrombosis: the debate goes on]. (2002) (1)
- Antiphospholipid antibodies and cardiovascular disease (1993) (1)
- [Neurological manifestations of the antiphospholipid syndrome]. (2005) (1)
- AB0504 CLINICOPATHOLOGICAL CHARACTERISTICS AS POSSIBLE PREDICTOR OF RENAL OUTCOME IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS FOLLOWING THE INDUCTION OF REMISSION PHASE (2019) (1)
- The effect of anti-Ro antibody of the fetus in the absence of overt congenital complete heart (2002) (1)
- Advances in Lupus and Sjögren's Syndrome (2007) (1)
- The Endovascular Compartment (1998) (1)
- B Cell Depletion therapy and Pregnancy Outcome in Severe Refractory Autoimmune Disease (2011) (0)
- Immunemediated mechanism forthrombosis: antiphospholipid antibody binding toplatelet membranes* (1988) (0)
- Anticardiolipin antibodies and cardiovascular disease. (1996) (0)
- Chapter 14 – Global Antiphospholipid Syndrome Score (2017) (0)
- Hughes syndrome: 'sticky blood'. (2009) (0)
- Detection andimportance ofanticardiolipin antibodies (1993) (0)
- The role of antiaggregant and anticoagulant therapy in the treatment of headache in systemic lupus erythematosus (2000) (0)
- Mormed Project: A New 21st Century Web Platform for Multilingual Communication in systemic Lupus Erythematosus and Antiphospholipid Syndrome (2012) (0)
- Syndrome des antiphospholipides et grossesse (2012) (0)
- Antiphosphatidylserine/Prothrombin Antibodies in Systemic Lupus (2014) (0)
- A pioneer in clinical diagnostics (2007) (0)
- Book Review: Publishing your medical research paper. What they don't teach you in Medical School Byrne DW (1999) (0)
- The Cost of Management of Adult Active Systemic Lupus Erythematosus in the UK. (2012) (0)
- Tests for Hughes Syndrome (2013) (0)
- SP0153 Lessons from aps trials (2017) (0)
- Chapter 17 Treatment of Late Pregnancy Complications in the Antiphospholipid Syndrome (2009) (0)
- of Rheumatology ' ' Non-criteria ' ' Antiphospholipid Antibodies Closing the Serological Gap in the Antiphospholipid Syndrome : The Value of (2017) (0)
- Iconography : Manifestations osseuses du syndrome des antiphospholipides (2007) (0)
- Chapter 15 Treatment of Thrombosis in the Antiphospholipid Syndrome (2009) (0)
- Clinical presentation of antiphospholipid syndrome (2021) (0)
- Anti-c1q autoantibodies as a predictor of lupus nephritis. (2003) (0)
- The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus (2015) (0)
- Unmonitored low molecular weight heparin (Dalteparin) in high-risk pregnancies (2000) (0)
- [Trichomegaly: an exceptional expression of the acquired immunodeficiency syndrome]. (1989) (0)
- O21 BILAG2004-Pregnancy index is sensitive to change (2018) (0)
- Neuropsychiatric manifestations in the antiphospholipid (Hughes) syndrome (2004) (0)
- Clinical Studies Examining Thrombosis Related to Autoimmune Antiphospholipid Antibodies~!2009-09-20~!2009-09-25~!2010-03-11~! (2010) (0)
- Mortality, Morbidity, and Damage Associated with aPL (2010) (0)
- CE-10 Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort (2016) (0)
- Apolipoprotein(a) deposition in atherosclerotic coronary arteries of a patient with systemic lupus erythematosus: comment on the article by Romero et al - Reply (2000) (0)
- treatment 10 in the pathogenesis of the disease and effects of coenzyme Q Mitochondrial dysfunction in antiphospholipid syndrome: implications (2014) (0)
- 801 Factors associated with SLE flares after HCQ taper, discontinuation or maintenance in the SLICC inception cohort: lower education linked with higher flare risk (2021) (0)
- The BILAG2004-pregnancy index for assessment of SLE disease activity in pregnancy is sensitive to change (2008) (0)
- Other Biological Therapies in Primary Sjögren’s Syndrome (2011) (0)
- Treatment of antiphospholipid syndrome (2021) (0)
- Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome (2010) (0)
- Comprar Autoimmune Diseases | Khamashta, Munther A. | 9780857293572 | Springer (2011) (0)
- The BILAG2004-pregnancy index has construct and criterion validity (2008) (0)
- Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function (2012) (0)
- Impaired trophoblast invasion in antiphospholipid syndrome pregnancies: Longitudinal analysis of insulin-like growth factor-I and Insulinlike growth factor binding protein-1. (2002) (0)
- Intestinal Behçet's Disease (2017) (0)
- Diagnosis and Classification (2019) (0)
- Membranous lupus nephritis: An update. (2003) (0)
- Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS) RHEUMATOLOGY (2014) (0)
- BILAG-2004 index: A reliable tool for assessment of SLE activity (2005) (0)
- Autoimmune and connective tissue disorders (2012) (0)
- Liver and Gastrointestinal Tract (2013) (0)
- 39 Management of Thrombosis in the Antiphospholipid Syndrome (2000) (0)
- “Endotheliology” in Antiphospholipid Antibodies (2001) (0)
- Preliminary Rasch analysis of SLEDAI-2000 index: An ordinal scale index with internal construct validity (2006) (0)
- Patient care pathways for pregnancy in rare and complex rheumatic diseases: results from an international survey. (2023) (0)
- matomyositis: aclinical review (1989) (0)
- Case reports 1. IGG4 Related Fibrosis: A Treatable Disease. Four Cases in a District General Hospital (2011) (0)
- Comparison of thalidomide toxicity profiles in treatment of Lupus and myeloma: Efficacy and toxicity are not dose dependent. (2002) (0)
- [Diabetic cheirarthropathy simulating sclerodermia]. (1990) (0)
- Reproductive issues in rheumatology: do you know how to advise your patients?I1. Is pregnancy a stress test for subsequent development of autoimmunity? (2012) (0)
- Antiphospholipid antibodies and HLA associations in primary S jogren ' s syndrome (0)
- Sifalimumab Slows Disease Activity in SLE (2014) (0)
- Correction of Previews 200100168381. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. Correction of title.) (2001) (0)
- Antiphosphollpid antibodies in sickle cell disease (1994) (0)
- What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome? (2022) (0)
- THU0013 Longterm Outcomes of Children Born to Mothers with SLE Exposed to Azathioprine in Pregnancy (2014) (0)
- The BILAG-2004 index is associated with development of new damage in SLE. (2022) (0)
- C URRENT OPINION Targeted therapy in antiphospholipid syndrome (2014) (0)
- Antiphospholipid antibodies inhomozygous sickle cell disease (1992) (0)
- Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally (2022) (0)
- Late pregnancy complications in systemic lupus erythematosus and antiphospholipid syndrome. (1997) (0)
- Arteries and Veins (2013) (0)
- OP0086 Eular Recommendations for Women's Health and the Management of Family Planning, Assisted Reproduction, Pregnancy, and Menopause in Patients With Systemic Lupus Erythematosus and/or the Antiphospholipid Syndrome (2015) (0)
- Kawasaki syndrome: the Florentine experience (1996) (0)
- Chapter 16 - Treatment of Thrombosis in Antiphospholipid Syndrome (2017) (0)
- OP0120 A Systematic Analysis of the Safety of Prescribing Anti-Rheumatic Immunosuppressive and Biologic Drugs in Pregnant Women with Inflammatory Arthritis (2014) (0)
- Book Review: Systemic Lupus Erythematosus. Third edition. Robert G Lahita (Ed) (1999) (0)
- 311 INFLAMMATION, LEUKOCYTE ACTIVATION, AND SURROGATE ATHEROSCLEROSIS MARKERS IN RHEUMATOID ARTHRITIS PATIENTS ARE RELATED TO MITOCHONDRIAL DEPOLARISATION AND OXIDATIVE STRESS (2011) (0)
- INCREASED RATE OF LUPUS FLARE DURING PREGNANCY AND THE PUERPERIUM : A PROSPECTIVE STUDY OF 78 PREGNANCIES (1996) (0)
- OP0252 NEUROPATHIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL, INCEPTION COHORT STUDY (2019) (0)
- [Systemic autoimmune diseases during pregnancy: a practical approach]. (1998) (0)
- 92 – ANTICARDIOLIPIN ANTIBODIES (2007) (0)
- CT-03 Anifrolumab reduces disease activity in multiple organ domains in patients with moderate to severe systemic lupus erythematosus (2016) (0)
- Systemic Lupus Erythematosus: Indirect B-Cell Blocking (2014) (0)
- CE-21 The prevalence and determinants of ANTI-DFS70 antibodies in an international inception cohort of systemic lupus erythematosus (SLE) patients (2016) (0)
- Premature cardiovascular disease in SLE: A study from a tertiary referral centre. (2003) (0)
- 126 Cross sectional validation of BILAG2004-Pregnancy Index (2018) (0)
- Incorrect Values for Intractable and Cluster Headaches at Enrollment Shown in Figure 1 and Incorrect Prevalence of Headache at Ten Years in Text of the Article by Hanly et al (Arthritis Rheum, November 2013) (2014) (0)
- BSR AND BHPR ORAL PRESENTATION OF ABSTRACTS CONNECTIVE TISSUE DISEASES (2015) (0)
- THU0635 Pregnancy outcomes in mixed connective tissue disease: results from a multicentre cohort study (2018) (0)
- risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome (0)
- SLE and antiphospholipid syndrome 168. Dyslipidaemia, Hyperhomocysteinaemia and Antiphospholipid Antibodies as Risk Factors of Thrombotic Complications in Patients with Systemic Lupus Erythematosus (2011) (0)
- Protein Z gene polymorphisms in systemic lupus erythematosus (2008) (0)
- version of SELENA comparison of BILAG 2004 and the flare with systemic lupus erythematosus : a An assessment of disease flare in patients (0)
- Anti-c1q in lupus nephritis: Strong correlation between titres and renal disease activity. (2003) (0)
- 14th International Congress on Antiphospholipid Antibodies - APLA & 4th LACA - Latin American Congress on Autoimmunity (2013) (0)
- I70 Development of Evidence-Based Recommendations for Diagnosis, Assessment and Treatment of Lupus (2016) (0)
- BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care (2013) (0)
- Pregnancy ingranulomatous vasculitis (1995) (0)
- AB0839 The efficacy and safety of denosumab local experience) (2017) (0)
- Targeting B Cells in Other Systemic Autoimmune Diseases (2014) (0)
- A SYSTEMATIC ANALYSIS OF THE SAFETY OF PRESCRIBING OF ANTI-RHEUMATIC, IMMUNOSUPPRESSIVE AND BIOLOGIC DRUGS IN PREGNANT WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASE (2013) (0)
- Treatment of Pregnancy Complications in Antiphospholipid Syndrome (2017) (0)
- Birmingham Construction of a frailty index as a novel health measure in systemic lupus erythematosus (2019) (0)
- Intensity and duration of oral anticoagulation in antiphospholipid antibody associated thrombosis. (2002) (0)
- Hematological Immune Cytopenias and Anti-Phospholipid Antibodies (2020) (0)
- RHEUMATIC DISEASES Leader The ANCA test : its clinical relevance (0)
- Complement deficiency in systemic lupus erythematosus (2003) (0)
- [Thrombocytopenia, pregnancy and systemic lupus erythematosus]. (1987) (0)
- Running Head : Economic Evaluation of Lupus Damage in an International Inception Cohort Title : Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach (2019) (0)
- CS-07 Economic evaluation of damage accrual in an international SLE inception cohort (2018) (0)
- Low frequency of IgA anticardiolipin antibody in patients with systemic lupus erythematosus (2000) (0)
- Antiprothrombin antibodies: Detection, immunological characteristics and clinical significance in patients with systemic lupus erythematosus. (2002) (0)
- [Lipoproteins and atherosclerosis in systemic lupus erythematosus]. (1992) (0)
- CE-22 Cancer in systemic lupus erythematosus: results from the slicc inception cohort (2016) (0)
- Multiple microinfarcts in the Hughes/antiphospholipid syndrome (APS) (2000) (0)
- Plasma levels of TNF alpha are increased in patients with the antiphospholipid syndrome (2000) (0)
- [Acute cerebral organic syndrome, systemic lupus erythematosus and antiphospholipid antibodies]. (1989) (0)
- [Role of platelet phospholipases in the antiphospholipid antibody syndrome]. (1988) (0)
- Classification Criteria for APS (2010) (0)
- Systemic lupus erythematosus (2001) (0)
- Length of gestation in systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS): Survival analysis of 282 pregnancies in 152 women. (2002) (0)
- 205 Correlation of Soluble Vascular Cell Adhesion Molecule 1 with B Cell Activation and Plasma Cells in Systemic Lupus Erythematosus (2016) (0)
- 414 OXIDATIVE STRESS MEDIATES APL-INDUCED THROMBOSIS AND ATHEROSCLEROSIS DEVELOPMENT IN ANTIPHOSPHOLIPID SYNDROME (2011) (0)
- Comments on the Editorial “Antiphospholypid Syndrome: New Clinical and Therapeutic Perspectives” (2007) (0)
- Differences Between Primary and Secondary APS (2010) (0)
- 40 – THE CLINICAL ASPECTS OF THE ANTIPHOSPHOLIPID SYNDROME (2004) (0)
- Outcome of 35 treated pregnancies in women with primary antiphospholipid syndrome. (2002) (0)
- aPL and Transplantation (2010) (0)
- Systemic Lupus Erythematosus, Antiphospholid Syndrome, Scleroderma, and Inflammatory Myopathies (2001) (0)
- Delay in recognising other causes contribute to fetal loss in women with antiphospholipid antibodies (2000) (0)
- Antiphospholipid antibodies in sickle cell disease. (1994) (0)
- Lupus comes of age. (1992) (0)
- The Sixth International Lupus Conference, Barcelona 24–28 March 2001 (2001) (0)
- Systemic lupus erythematosus in50year olds (1992) (0)
- Neuropsychiatric lupus: Relevance of Antiphospholipid antibodies. (2002) (0)
- Chapter 87 – Anticardiolipin Antibodies (2014) (0)
- Complicated Pregnancies in Patients with Autoimmune Systemic Diseases (2011) (0)
- Complement factor 2 deficiency: serological family study (2004) (0)
- Chapter 13 Endocrine Manifestations of the Antiphospholipid Syndrome (2008) (0)
- BILAG-2004 captures SLE disease activity better than SLEDAI-2000 (2005) (0)
- inapatient withlupus anticoagulant andthrombosis (1989) (0)
- Antiprothrombin antibodies in infections and antiphospholipid syndrome (2000) (0)
- Hypertension in primary antiphospholipid syndrome. (2003) (0)
- Chapter 47 – Treatment of Antiphospholipid Syndrome (2007) (0)
- 322. Patients with Refractory Systemic Lupus Erythematosus Requiring Biologic Therapy Have Significant Levels of Baseline Co-Morbidities: Results from a National Multi-Centre Register (2014) (0)
- Patients with learning disability in the community (1999) (0)
- ELISA using Thrombofax is useful to verify antiphospholipid antibodies. (1990) (0)
- [Sneddon syndrome and antiphospholipid antibodies]. (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Munther A. Khamashta?
Munther A. Khamashta is affiliated with the following schools: